Carbidopa, Levodopa And Entacapone
Product Images NDC 55648-784

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 55648-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lectaborion M Figure 01)

FDA Label Image

Structure (Lectaborion M Figure 02)

FDA Label Image

Structure (Lectaborion M Figure 03)

FDA Label Image

Label (Lectaborion M Figure 04)

Label (Lectaborion M Figure 04)
This text provides information on the dosage and administration of Carbidopa, Levodopa, and Entacapone Tablets. It advises users to swallow the tablets whole and not crush, split, or chew them. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) in a tightly sealed container. The manufacturer of the tablets is Orion Corporation, Orion Pharma, in Finland, while the tablets are distributed in the USA by Wockhardt USALLC. A cautionary warning advises not to combine two lower strength products to achieve a higher strength product as it may lead to an overdose of entacapone. Each film-coated tablet contains Carbidopa USP. The text also provides the NDC number and size (100 tablets). Overall, this text provides useful information on the Carbidopa, Levodopa, and Entacapone Tablets for users.*
FDA Label Image

Label (Lectaborion M Figure 05)

Label (Lectaborion M Figure 05)
Carbidopa, Levodopa and Entacapone Tablets are designed to lessen the symptoms of Parkinson's disease by increasing levels of the natural substances dopamine and levodopa. The recommended dosage can be found in the package insert and the tablets should not be crushed, split, or chewed. These tablets should be stored in a tight container at a temperature range of 15°C to 30°C (59°F to 86°F). The tablets are manufactured by Orion Pharma in Finland and distributed by Wockhardt USA LLC in the USA. Each tablet of this product contains 31.25 mg of Carbidopa USP, 125 mg of Levodopa USP, and 200 mg of Entacapone. It is important not to combine two lower strength products to make a higher strength medication, to avoid possible overdose of Entacapone.*
FDA Label Image

Label (Lectaborion M Figure 06)

Label (Lectaborion M Figure 06)
Carbidopa, Levodopa And Entacapone Tablets is a prescription drug that is manufactured by QOrion Corporation and distributed by Wockhardt USA LLC. It contains Carbidopa and Levodopa along with Entacapone. The tablets are film-coated and should be swallowed whole. Crushing, splitting, or chewing them is not recommended. It is advised to keep the medicine at room temperature, i.e., 25°C (77°F), and away from children. Each tablet has 200mg of Entacapone, and combining two lower strength products is not advisable as it may lead to an overdose.*
FDA Label Image

Label (Lectaborion M Figure 07)

Label (Lectaborion M Figure 07)
This is a medication with the generic name Carbidopa, Levodopa And Entacapone Tablets, manufactured by Orion Corporation. It's recommended to swallow the tablet whole and not to crush, chew, or split it. The tablets should be kept in a tight container at room temperature. The medication comes in 100 tablets and is distributed by Wockhardt USALLC. The package insert recommends not combining two weaker strength products to achieve a higher strength product as it may lead to an overdose of Entacapone.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.